Biliary Tract Disease: Gallstones and Acute Cholecystitis

0:00Welcome to Board Pearls. This is episode one of four of the Biliary Tract Disease chapter, in the Pancreatic and Biliary Disease module. This episode is gallstone disease and acute cholecystitis: the stone types and what each one tells you about the biochemistry that made it, when symptomatic stones send a patient to cholecystectomy, how acute cholecystitis is graded and timed, and the acalculous and emphysematous variants that change the host risk and the urgency.

0:27Stones are the entry point because they explain almost everything else the gallbladder does to a patient, since the phenotype of the stone tells you what biochemical environment produced it, and that environment is really the risk-factor list seen from the mechanism side. Three phenotypes, three environments. Cholesterol stones are the dominant Western stone, about three-quarters of the total, yellow-brown, crystalline, and usually lucent on plain film, and they form when bile turns lithogenic, which happens through any combination of three pathways. The first is cholesterol supersaturation, where raised cholesterol, lowered bile salts, or lowered phospholipids tip the solubility math so cholesterol falls out of solution. The second is gallbladder dysmotility, where stasis prolongs the contact between supersaturated bile and the mucosa, and the longer that contact, the more cholesterol nucleates. And the third is the nucleus itself, where mucin, bacteria, ceftriaxone-calcium crystals, or various proteins seed crystalline cholesterol into a stone.

1:28Almost every gallstone risk factor lines up with one of those three. Estrogen, parity, and hormonal therapy raise hepatic cholesterol secretion and drive supersaturation, progesterone slows the gallbladder by relaxing its smooth muscle, which is dysmotility, and obesity, hyperlipidemia, diabetes, and certain ancestries raise supersaturation through inherited or acquired cholesterol traits. Rapid weight loss from bariatric surgery, very-low-calorie diets, or TPN removes the postprandial gallbladder stimulus and creates stasis, vagotomy and diabetic autonomic neuropathy abolish vagal contraction, and octreotide inhibits contractility directly. Ileal disease and resection interrupt the enterohepatic circulation and shrink the bile-salt pool, removing the solvent for biliary cholesterol, and the phospholipid-transporter mutations keep phospholipid out of bile so it can't solubilize cholesterol.

2:22The classic mnemonic of female, forty, fertile, fat, and fair captures the demographics, but ethnicity layers on top, with some Native American populations approaching a fifty-to-sixty-percent adult prevalence, so pregnancy in a woman of Indigenous or South American ancestry stacks hormonal supersaturation onto inherited supersaturation, and that's the high-yield vignette.

2:45Black pigment stones are a different chemistry, calcium bilirubinate and calcium phosphate, hard, and often opaque on plain film, and they form when unconjugated bilirubin delivery to the gallbladder exceeds solubilizing capacity, which happens in chronic hemolysis, so think sickle cell disease, hereditary spherocytosis, thalassemia, and mechanical valves or assist devices with shear hemolysis, and in Gilbert syndrome where the conjugating enzyme is deficient, and in cirrhosis and cystic fibrosis and Crohn disease. So if the stem hands you a mechanical valve or a sickle cell patient with stones, the phenotype is black pigment and the mechanism is excess unconjugated bilirubin.

3:22Brown pigment stones are the third and the easiest to miss, soft, greasy, completely lucent, made of unconjugated bilirubin, mucin, cholesterol, and fatty acids, and they don't form in the gallbladder, they form new in the bile duct itself under stasis plus bacterial infection, because bacterial enzymes deconjugate bilirubin in the duct and the unconjugated bilirubin precipitates with calcium. That explains a counterintuitive observation: brown pigment stones are the most common stone appearing more than two years after cholecystectomy, because by then any retained gallbladder stone has declared itself and what you're seeing is fresh ductal genesis, which is why they associate with biliary stricture, duodenal diverticulum, post-sphincterotomy anatomy, and biliary parasites. Time since cholecystectomy is the pivot: within two years suspect a retained stone, beyond two years suspect a brown pigment de novo stone and start looking for the stasis driver. And one factor sits outside the three pathways, ceftriaxone, which precipitates as calcium-ceftriaxone crystals and seeds stones directly, so a single course can produce stones in a previously stone-free patient, and the vignette is a child or adult who developed sludge or stones during or shortly after a ceftriaxone course.

4:38Now the clinical question: the patient has stones, what do you do. About ten percent of adults have stones and three-quarters of those are asymptomatic, and the observation-versus-surgery math is straightforward, because asymptomatic stones progress to symptomatic disease at only one to four percent per year while elective cholecystectomy carries a small but real perioperative mortality, so the progression rate doesn't exceed the operative risk and the answer is observation. Once the patient becomes symptomatic the math flips, because although about a third stay asymptomatic after a first colic episode, the rest face a meaningful yearly risk of severe complications, which tilts toward surgery in any fit patient.

5:18Biliary colic is the only symptom clearly attributable to stones, a severe epigastric or right-upper-quadrant pain lasting thirty minutes to several hours, often radiating to the right shoulder or scapula, frequently after fatty meals because the gallbladder contracts against an obstructing stone, and often nocturnal, with pain-free intervals of days to months, and that intermittent severe pain with full resolution between attacks is the recognition pattern that triggers cholecystectomy referral.

5:45What biliary colic is not is dyspepsia, because bloating, fullness, belching, and vague upper-abdominal discomfort occur at identical rates in patients with and without stones, so dyspepsia is not attributable to stones and the historical relief of dyspepsia after cholecystectomy is largely a placebo effect, meaning a patient with stones and dyspepsia but no true colic probably has functional dyspepsia or irritable bowel, and cholecystectomy won't help, a point we'll return to next episode under functional gallbladder disorder, because over-utilizing cholecystectomy for vague upper-abdominal pain is a favorite teaching point.

6:16There's a small high-yield list of asymptomatic situations where prophylactic cholecystectomy is still offered, and the organizing principle is that a cancer or surgical-emergency risk has shifted the calculus far enough to operate before symptoms arrive. A porcelain gallbladder with patchy or incomplete calcification gets surgery, because the non-calcified mucosa can still harbor progressing dysplasia, whereas a completely calcified burnt-out wall carries lower cancer risk and can be observed in selected patients.

6:46Stones three centimeters or larger carry roughly ten times the gallbladder cancer risk of small stones, because chronic mechanical irritation drives metaplasia to dysplasia to carcinoma over decades. Polyps coexisting with stones combine two cancer-risk channels and warrant cholecystectomy. Native American women with stones carry a high enough baseline cancer risk to justify prophylactic surgery. A pancreaticobiliary maljunction with biliary cysts warrants cholecystectomy as part of cyst excision, because the gallbladder bears the brunt of the refluxate. And chronic Salmonella carriage, sickle cell with documented stones, and transplant evaluation are all listed indications, with bariatric candidates who have known stones often operated concurrently because the rapid postoperative weight loss precipitates symptomatic disease. The vignette is a Native American or Mexican-American woman with stones plus one of these modifiers, and the answer is cholecystectomy even though she's asymptomatic.

7:45Now the disease itself. When cystic duct obstruction stops being intermittent and becomes persistent, colic becomes acute cholecystitis, and the mechanism is mechanical first and inflammatory second: bile concentrates behind the obstructing stone, the mucosa liberates an irritant lipid from membrane phospholipid, the wall mounts a chemical inflammation, and bacterial superinfection completes it, so the pain becomes constant rather than colicky and you get fever, leukocytosis, and a positive Murphy sign. One pearl on the liver tests: in uncomplicated cholecystitis the liver chemistries are normal or only modestly raised, generally under twice normal, so a marked transaminase or bilirubin elevation in what looks like cholecystitis is your signal to widen the differential to either concurrent duct stones or Mirizzi syndrome, where an impacted cystic duct stone compresses the common hepatic duct, both covered in the next episodes, but the pattern starts here: a big bilirubin in a cholecystitis vignette means look at the duct.

8:45The Tokyo Guidelines establish the diagnosis by requiring agreement across three things, because each alone is nonspecific: local signs like a Murphy sign, a right-upper-quadrant mass, and tenderness; systemic signs like fever, leukocytosis, and a raised CRP; and confirmatory imaging. Right-upper-quadrant pain, leukocytosis, and gallbladder wall findings each have long differentials, so it takes all three agreeing to make the diagnosis. Imaging starts with a right-upper-quadrant ultrasound, where a sonographic Murphy sign, meaning the probe compresses the gallbladder and reproduces the pain, plus wall thickening greater than three and a half millimeters, pericholecystic fluid or edema, and distension over four centimeters transverse, all support it. When ultrasound is equivocal or you suspect acalculous disease, the nuclear HIDA scan is second-line, and its mechanism is what makes it definitive rather than merely consistent: if the tracer fills the bile duct and the small bowel but cannot enter the gallbladder, the cystic duct is obstructed by definition, which is radiographic proof of the disease.

9:55Once you have the diagnosis, how aggressively to operate is set by the Tokyo grade, and the logic is that each level of organ stress shortens the window before the patient can no longer tolerate decompression, while each level of inflammation distorts the operative anatomy further. Grade one is mild, with no organ dysfunction, managed with antibiotics and fluids for stabilization then early laparoscopic cholecystectomy within the admission, usually within seven days, because in that first week the planes of Calot's triangle still separate, whereas waiting lets the inflammatory rind blur the cystic duct, cystic artery, and common bile duct and raises the risk of duct injury.

10:36Grade two is moderate, defined by leukocytosis above eighteen thousand, a palpable mass, symptoms beyond seventy-two hours, or marked local inflammation like gangrenous or emphysematous change, and antibiotics start immediately, with early cholecystectomy still preferred at high-volume centers, but if dense inflammation has already matured, the alternative is percutaneous drainage now and delayed cholecystectomy in about six weeks once the planes return, a decision that weighs anatomic risk against patient stability and is institution-dependent.

11:06Grade three is severe, with organ dysfunction, and this patient cannot survive an immediate operation, so the sequence is ICU resuscitation plus emergent gallbladder drainage for source control, with cholecystectomy deferred to after recovery and sometimes never done, the catheter or stent becoming definitive.

11:26The mortality numbers anchor the urgency: elective cholecystectomy carries a very low operative mortality, while acute cholecystitis itself runs five to ten percent across all comers, concentrated in older patients with comorbidity and in suppurative complications, and that gap is why intervening early, before suppuration matures, is the goal.

11:45For the poor surgical candidate the drainage options have changed, because the current therapeutic guideline now prefers endoscopic-ultrasound-guided gallbladder drainage with a lumen-apposing metal stent over percutaneous transhepatic drainage where local expertise allows, and the reason is internalization: the endoscopic approach creates a permanent fistula from the gallbladder into the duodenum or stomach with no external drain to care for, no exit-site infection, and no nursing burden, and it produced higher clinical success and fewer reinterventions than percutaneous drainage. An ERCP with a transpapillary cystic duct stent is a third option when neither is available. The contraindications to the endoscopic stent line up with mechanism: perforation, uncontrolled coagulopathy, large-volume ascites which displaces the gallbladder from the gut wall and prevents the flanges from apposing, a poor endosonographic window, and critically emphysematous cholecystitis, because that wall is already ischemic and friable and any transmural intervention risks catastrophic perforation, which is the bridge to the last topic.

12:46The variants change the host risk, the urgency, and the procedure. Acalculous cholecystitis is a small fraction of cases but its mortality is dramatically higher, often cited at thirty to fifty percent in the critically ill, driven by two mechanisms. The first is delayed diagnosis, because the classic patient is intubated, sedated, on TPN, with competing diagnoses already listed, and you can't elicit right-upper-quadrant tenderness from a sedated patient, so new unexplained sepsis or worsening leukocytosis is sometimes the only signal and it's nonspecific in the ICU. The second is pathogenesis, because gallbladder ischemia from low-flow states plus functional cystic duct obstruction from inspissated bile during fasting drives gangrenous progression faster than calculous disease, so the host is sicker and the disease is faster.

13:39Its imaging shows the same wall thickening, pericholecystic fluid, mucosal changes, and distension, but every one of those is nonspecific in the critically ill, because TPN, low albumin, third-spacing, and right heart failure reproduce them in a normal gallbladder, which is why a HIDA scan with morphine augmentation becomes the tiebreaker, since morphine constricts the sphincter and forces tracer into a patent cystic duct, so failure to fill the gallbladder under that stress supports obstruction, though false positives from prolonged fasting make it supportive rather than definitive, and the real task is to consider the diagnosis early in any ICU patient with new tenderness or unexplained sepsis.

14:13Emphysematous cholecystitis is the gas-forming variant, where clostridial or enteric organisms infect an ischemic wall and produce gas in the lumen, wall, or surrounding tissue, with a gas crescent on imaging, typically in a diabetic patient with vascular disease, and rapid progression to gangrene and perforation, with a mortality several-fold higher than typical calculous disease because the wall is ischemic before infection and the gas-formers accelerate transmural necrosis from within.

14:36Management of both variants prioritizes rapid decompression with broad-spectrum antibiotics covering enteric gram-negatives, anaerobes, and clostridia in the emphysematous case, with piperacillin-tazobactam or a carbapenem covering the field, and the drainage decision shifts toward percutaneous cholecystostomy as the first-line option in the unstable patient, because it's bedside-deployable, doesn't require the gallbladder to appose the gut wall, and avoids the catastrophic perforation risk of a transmural stent through a friable ischemic wall, which is exactly why the guideline names emphysematous cholecystitis as a contraindication to the endoscopic stent. Laparoscopic or open cholecystectomy is preferred when the patient is stable enough to tolerate it, and gangrene, perforation, or peritonitis force operation regardless of stability because delay itself becomes fatal, while after percutaneous drainage in an acalculous survivor an interval cholecystectomy is done if the patient becomes a surgical candidate, though in many ICU survivors the catheter is definitive because the ischemic insult is no longer active.

15:29So the way of thinking to leave with: the stone phenotype reveals the biochemistry that made it, and that biochemistry is the risk-factor list from the mechanism side, with cholesterol stones from supersaturation, dysmotility, or nucleation, black pigment stones from excess unconjugated bilirubin, and brown pigment stones forming new in ducts under stasis plus bacterial deconjugation, which is why time since cholecystectomy splits retained stones from new ones. Asymptomatic stones are observed because the math favors it, unless a cancer or surgical-emergency configuration shifts the calculus, and once true biliary colic appears, cholecystectomy is the answer. When persistent obstruction converts colic into cholecystitis, the Tokyo grade dictates how aggressively to operate, from early laparoscopic surgery in mild disease, to early surgery at experienced centers or delayed surgery after drainage in moderate disease, to drainage and ICU support first in severe disease, with the endoscopic stent now preferred in the poor surgical candidate with stable anatomy, and the friable ischemic wall of the acalculous and emphysematous variants pushing drainage back toward the percutaneous route.

16:37The next episode picks up the less common gallbladder presentations organized around chronic remodeling and rare mechanisms: Mirizzi syndrome and the staging that governs its reconstruction, porcelain gallbladder and the calcification pattern that decides whether you operate, gallstone ileus and Bouveret syndrome with the classic radiographic triad and the level-of-impaction logic, gallbladder polyps and adenocarcinoma with their size thresholds, and the functional gallbladder disorder where over-utilization is the dominant risk.

17:02For the full chapter, the practice vignettes, and the topic-tagged question bank, head to board pearls dot com. You'll find the rest of the series on Apple Podcasts, Spotify, or wherever you listen to podcasts. That brings us to the end of episode one of four of chapter twenty-seven, and I'll see you in the next one.